BioNTech SE: BioNTech and Fosun Pharma Provide COVID-19 Vacc

Approximately 11,500 of the companies' mRNA-based COVID-19 vaccine doses arrived on the Chinese Mainland to enable vaccination campaign for German expatriatesVaccines expected to be available in Beijing

Related Keywords

China , Guangzhou , Guangdong , Chengdu , Sichuan , Germany , Taiwan , Shanghai , Hong Kong , Li Shengli , Zhanghua Xian , Shenyang , Liaoning , Beijing , Hong Kong Special Administrative Region , Hong Kong General , Macau , Chinese , German , Sylke Maas , Barney Liu , Sean Marett , Fosun Pharma , Stock Exchange Of Hong Kong , Genentech , Sinopharm Co Ltd , Fosun Pharma Or Group , Shanghai Fosun Pharmaceutical Group Co Ltd , Shanghai Stock Exchange , Pfizer , Roche Group , Chinese Mainland , Stock Code , Chief Business , Commercial Officer , Executive President , Chief Growth Officer , Greater China Market , Emergency Use Authorization , Special Import Authorizations , New Technologies , Private Securities Litigation Reform Act , Shanghai Fosun Pharmaceutical , Annual Report , Interim Report , Stock Exchange , Hong Kong Limited , Biontech , Osun , Dharma , Rovide , Covid , Vaccine , Doses , Vaccination , Expatriates ,